The longtime college aid program is expanding to cover short-term vocational and technical training. To realize its full ...

July 1 marks the official opening of a program that allows federal dollars to go toward short-term workforce training ...

Alabamians who want to train for in-demand jobs without committing to a traditional degree program could soon have a new way ...

The country wants to become a global leader in brain implants. Strong government support is expected to help accelerate that process. One day last October, sitting in the courtyard of his house in ...

Donald Trump's approval rating is about 38%-40% on average, according to aggregators. The latest Economist/YouGov poll found his approval is at a career low. President Donald Trump's endorsement ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. President Donald Trump’s approval ratings have fallen to new lows ...

For serious conditions with high unmet need, earlier access to promising treatments can be worth the risk of greater uncertainty. But achieving this balance demands trust. Marty Makary’s resignation ...

On Thursday the White House released long-anticipated draft regulations that, if enacted, would give political appointees the final word on federal research grants and other funding across government ...

FDA's Adam Fisher speaks at the 2026 REdI meeting. (Source: REdI) Adam Fisher, the staff director of the Office of Pharmaceutical Quality in the Center for Drug Evaluation and Research (CDER) at the ...

NEW YORK CITY (WABC) -- New York City Comptroller Mark Levine is investigating why so few outdoor dining setups are operating, and why so many seem stuck in city bureaucracy. The comptroller's letter ...

Iowa colleges and universities can now apply to take part in a program which awards a new federal Workforce Pell grant to low-income students pursuing short-term, nondegree programs. The state is the ...

White Oak, Md., May 08, 2026 (GLOBE NEWSWIRE)-- The U.S. Food and Drug Administration today issued an approval for Bizengri (zenocutuzumab-zbco), a drug that treats NRG1 fusion-positive ...